Rohto Pharmaceutical Co.,Ltd. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
The price is attractive. You pay 12.2× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -0% yearly growth; analysts expect 5%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is adequate. The company scores 13/20 on our value-creation score: creating some value.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202347
87
2023202420252026
All-time high
87
Jun 2026
All-time low
36
Jan 2024
Average rank
63
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
37
52
42
56
Price/Earnings
57
62
51
49
Price/Book
53
34
37
59
Dividend Yield
61
52
39
31
Value (overall)
47
59
40
51
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.